A Phase I Dose Escalation and Expansion Study of Epidiolex (Cannabidiol) in Patients with Biochemically Recurrent Prostate Cancer

SIMPLE SUMMARY: Cannabinoids have been widely used for pain, nausea, and appetite stimulation, and have also shown anti-tumor activity in preclinical studies of prostate cancer. Epidiolex is an oral cannabidiol solution that is FDA approved for the treatment of certain types of seizures in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Myint, Zin W., St. Clair, William H., Strup, Stephen E., Yan, Donglin, Li, Ning, Allison, Derek B., McLouth, Laurie E., Ellis, Carleton S., Wang, Peng, James, Andrew C., Hensley, Patrick J., Otto, Danielle E., Arnold, Susanne M., DiPaola, Robert S., Kolesar, Jill M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177512/
https://www.ncbi.nlm.nih.gov/pubmed/37173971
http://dx.doi.org/10.3390/cancers15092505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177512/
https://www.ncbi.nlm.nih.gov/pubmed/37173971
http://dx.doi.org/10.3390/cancers15092505

Ejemplares similares